The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents.
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia.
Matthew L
ML
Banks
Ohio Attorney General's Bureau of Criminal Investigation, London, Ohio.
Travis J
TJ
Worst
Departments of Emergency Medicine and Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana.
Daniel E
DE
Rusyniak
The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, Ohio.
Jon E
JE
Sprague
D000470:Alkaloids / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D015198:Designer Drugs / Q000009:adverse effects*; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects*; D019966:Substance-Related Disorders
D000470:Alkaloids; D000697:Central Nervous System Stimulants; D015198:Designer Drugs; D011619:Psychotropic Drugs